Putnam Investments’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $91.4M | Sell |
|
|||||
|
2023
Q3 | $72.3M | Sell |
|
|||||
|
2023
Q2 | $80.3M | Buy |
|
|||||
|
2023
Q1 | $79.4M | Buy |
|
|||||
|
2022
Q4 | $86.3M | Sell |
|
|||||
|
2022
Q3 | $81.4M | Sell |
|
|||||
|
2022
Q2 | $74.7M | Buy |
|
|||||
|
2022
Q1 | $74.2M | Buy |
|
|||||
|
2021
Q4 | $67.4M | Buy |
|
|||||
|
2021
Q3 | $72.4M | Buy |
|
|||||
|
2021
Q2 | $55.4M | Buy |
|
|||||
|
2021
Q1 | $13M | Sell |
|
|||||
|
2020
Q4 | $35.1M | Sell |
|
|||||
|
2020
Q3 | $60.2M | Sell |
|
|||||
|
2020
Q2 | $86.1M | Buy |
|
|||||
|
2020
Q1 | $64.1M | Buy |
|
|||||
|
2019
Q4 | $24.2M | Buy |
|
|||||
|
2019
Q3 | $16.6M | Sell |
|
|||||
|
2019
Q2 | $28.6M | Buy |
|
|||||
|
2019
Q1 | $19.8M | Buy |
|
|||||
|
2018
Q4 | $9.96M | Sell |
|
|||||
|
2018
Q3 | $11.7M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $331K | Hold |
|
|||||
|
2015
Q1 | $326K | Buy |
|